The promise of big rewards for a successful drug treatment of NASH has spurred dozens of drug developers to try to develop the first therapy for the fatty liver disease, which affects millions of ...
Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback